Treatment options for TP53-mutated lymphoid tumors are very limited. In experimental models, TP53-mutated lymphomas were sensitive to direct inhibition of checkpoint kinase 1 (Chk1), a pivotal regulator of replication. We initially tested the potential of the highly specific Chk1 inhibitor SCH900776 to synergize with nucleoside analogs (NAs) fludarabine, cytarabine and gemcitabine in cell lines derived from B-cell malignancies. In p53-proficient NALM-6 cells, SCH900776 added to NAs enhanced signaling towards Chk1 (pSer317/pSer345), effectively blocked Chk1 activation (Ser296 autophosphorylation), increased replication stress (p53 and γ-H2AX accumulation) and temporarily potentiated apoptosis. In p53-defective MEC-1 cell line representing adverse chronic lymphocytic leukemia (CLL), Chk1 inhibition together with NAs led to enhanced and sustained replication stress and significantly potentiated apoptosis. Altogether, among 17 tested cell lines SCH900776 sensitized four of them to all three NAs. Focusing further on MEC-1 and co-treatment of SCH900776 with fludarabine, we disclosed chromosome pulverization in cells undergoing aberrant mitoses. SCH900776 also increased the effect of fludarabine in a proportion of primary CLL samples treated with pro-proliferative stimuli, including those with TP53 disruption. Finally, we observed a fludarabine potentiation by SCH900776 in a T-cell leukemia 1 (TCL1)-driven mouse model of CLL. Collectively, we have substantiated the significant potential of Chk1 inhibition in B-lymphoid cells.
Coherence-controlled holographic microscopy (CCHM) is a realtime, wide-field, and quantitative light-microscopy technique enabling 3D imaging of electromagnetic fields, providing complete information about both their intensity and phase. These attributes make CCHM a promising candidate for performance assessment of phase-altering metasurfaces, a new class of artificial materials that allow to manipulate the wavefront of passing light and thus provide unprecedented functionalities in optics and nanophotonics. In this paper, we report on our investigation of phase imaging of plasmonic metasurfaces using holographic microscopy. We demonstrate its ability to obtain phase information from the whole field of view in a single measurement on a prototypical sample consisting of silver nanodisc arrays. The experimental data were validated using FDTD simulations and a theoretical model that relates the obtained phase image to the optical response of metasurface building blocks. Finally, in order to reveal the full potential of CCHM, we employed it in the analysis of a simple metasurface represented by a plasmonic zone plate. By scanning the sample along the optical axis we were able to create a quantitative 3D phase map of fields transmitted through the zone plate. The presented results prove that CCHM is inherently suited to the task of metasurface characterization. Moreover, as the temporal resolution is limited only by the camera framerate, it can be even applied in analysis of actively tunable metasurfaces.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.